ニュースルーム / GVK Biosciences forms Clinical Research Alliance with Excel…

  • Font SizeAA

GVK Biosciences forms Clinical Research Alliance with Excel PharmaStudies, to conduct trials in India and China GVK BIO – Excel have decided to form an alliance to build on the strengths of each company and offer clients with services that span India and China.

Hyderabad, India (April 14, 2009)

GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Excel PharmaStudies (Excel), a leading Chinese Clinical Research Organization announced a strategic alliance to conduct Clinical Trials in Asia.

The alliance provides clinical trial sponsors access to the scientific skills, talent pool, flexible resourcing, and cost-effectiveness of both India and China.  India has sponsor friendly regulations and strength in Phase II/III clinical trials; China has strengths in its large market, Phase III and post marketing Phase IV studies; Through the GVK BIO-Excel alliance sponsors will be able to conduct Phase II-IV trials using India and China as required with speed and efficiency.

Under the terms of the arrangement, GVK BIO and Excel will help sponsors conduct and manage Phase II-IV clinical trials, statistical analysis and medical writing.  Any India trial for Excel will be carried out by the GVK BIO clinical research team and will be managed by a core project management team of Excel. Similarly, a GVK BIO China trial will be carried out by the Excel team and managed by GVK BIO’s project management team.

“This is a first of a kind alliance between an Indian CRO and a Chinese CRO. The GVK BIO-Excel alliance integrates trial management across India and China and provides sponsors with a single point of contact”, said Manni Kantipudi, President GVK BIO.

“It is an important step for Excel, and our clients, to be able to provide full services in both important countries”, said Dr. William Xiong, CEO Excel PharmaStudies.

The decision to form such an alliance comes close on heels of GVK Biosciences increased focus on Clinical Development. GVK BIO had recently strengthened its team by hiring Dr. Shoibal Mukherjee, ex-Pfizer as its Clinical Development Head. GVK BIO also added new services in pharmacovigilance and medical writing operating from its Clinical Research Facility in Gurgaon, India.


GVK Biosciences (, Asia’s leading Contract Research Organization, delivers integrated research services to Big Pharma and Biotech companies globally. GVK BIO accelerates the drug discovery and development process of its customers through science and innovation.  GVK BIO has a diverse customer portfolio including 15 Big Pharma companies, Agri & Life-sciences companies, leading biotechs and academic institutions. Headquartered in Hyderabad, India, GVK BIO has more than 1,500 employees spread across research facilities in Hyderabad, Mumbai and Gurgaon in India.  

About Excel PharmaStudies

Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China, with more limited operations throughout Asia. With 17 offices worldwide, nearly 300 staff members, and experience working with over 120 of the world’s leading global pharmaceutical and biotech companies, Excel PharmaStudies, Inc. has the resources, connections, and expertise needed to help you with all of your drug development needs in Asia.

For  Further information, please contact:

Sharada Alvakonda
Dy. General Manager – Corporate Communications
GVK Biosciences Private Limited
T   +91 40 66929999